Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether calcium and vitamin D supplementation, over
a nine-month period, optimizes bone mineralization in boys with risperidone-induced
hyperprolactinemia. We hypothesize that, by the end of the stuy, children in the
supplementation group will have higher bone mineral density compared to those in the placebo
group.
Phase:
Phase 3
Details
Lead Sponsor:
Chadi A. Calarge University of Iowa
Collaborators:
Children's Miracle Network National Institute of Mental Health (NIMH)
Treatments:
Calcium Calcium, Dietary Ergocalciferols Risperidone Vitamin D Vitamins